Belpointe Asset Management LLC Makes New $459,000 Investment in RELX PLC $RELX

Key Points

• Belpointe Asset Management LLC has acquired a new stake in RELX PLC, purchasing 9,110 shares valued at approximately $459,000 in the first quarter.
• RELX has announced a semi-annual dividend of $0.2634 per share, with a payout ratio of 28.49%, set to be paid on September 16th.
• Analysts have shifted their ratings on RELX, with Wall Street Zen lowering the stock from a "buy" to a "hold," although it still maintains an average rating of "Buy" across other analysts.

Belpointe Asset Management LLC acquired a new stake in RELX PLC (NYSE:RELX - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 9,110 shares of the technology company's stock, valued at approximately $459,000.

Several other hedge funds also recently modified their holdings of RELX. Cetera Investment Advisers increased its stake in shares of RELX by 8.6% in the 4th quarter. Cetera Investment Advisers now owns 55,460 shares of the technology company's stock valued at $2,519,000 after acquiring an additional 4,369 shares in the last quarter. Focus Partners Wealth increased its stake in shares of RELX by 84.9% in the 4th quarter. Focus Partners Wealth now owns 10,235 shares of the technology company's stock valued at $471,000 after acquiring an additional 4,701 shares in the last quarter. Two Sigma Investments LP grew its position in RELX by 88.9% in the 4th quarter. Two Sigma Investments LP now owns 75,318 shares of the technology company's stock valued at $3,421,000 after purchasing an additional 35,445 shares during the period. Two Sigma Advisers LP grew its position in RELX by 13.9% in the 4th quarter. Two Sigma Advisers LP now owns 68,463 shares of the technology company's stock valued at $3,110,000 after purchasing an additional 8,363 shares during the period. Finally, Vident Advisory LLC grew its position in RELX by 7.3% in the 4th quarter. Vident Advisory LLC now owns 26,190 shares of the technology company's stock valued at $1,190,000 after purchasing an additional 1,772 shares during the period. Institutional investors own 15.02% of the company's stock.

RELX Stock Down 1.1%

RELX traded down $0.52 during mid-day trading on Friday, reaching $47.09. 1,170,348 shares of the stock were exchanged, compared to its average volume of 1,506,443. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. The stock has a market capitalization of $86.30 billion, a PE ratio of 25.32, a price-to-earnings-growth ratio of 3.10 and a beta of 0.87. The company has a 50 day moving average price of $49.14 and a two-hundred day moving average price of $51.05. RELX PLC has a 1 year low of $44.19 and a 1 year high of $56.33.

RELX Cuts Dividend

The company also recently disclosed a semi-annual dividend, which was paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th were issued a dividend of $0.2634 per share. This represents a yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. RELX's payout ratio is currently 28.49%.

Analyst Ratings Changes

Several analysts recently issued reports on RELX shares. Wall Street Zen downgraded shares of RELX from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Morgan Stanley reissued an "overweight" rating on shares of RELX in a research report on Thursday, September 11th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of "Buy".

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.